(NASDAQ: WBA) Walgreens Boots Alliance's forecast annual revenue growth rate of 2.99% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Walgreens Boots Alliance's revenue in 2024 is $144,596,000,000.On average, 7 Wall Street analysts forecast WBA's revenue for 2024 to be $125,935,737,912,334, with the lowest WBA revenue forecast at $123,964,109,177,231, and the highest WBA revenue forecast at $127,558,641,513,345. On average, 7 Wall Street analysts forecast WBA's revenue for 2025 to be $130,660,128,847,223, with the lowest WBA revenue forecast at $128,924,748,128,406, and the highest WBA revenue forecast at $135,315,469,929,724.
In 2026, WBA is forecast to generate $136,657,780,322,011 in revenue, with the lowest revenue forecast at $129,986,489,467,942 and the highest revenue forecast at $143,777,135,166,125.